Expanded Access to Entrectinib for Cancers With NTRK1/2/3, ROS1, or ALK Gene Fusions
Clinical trial NCT03066661 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT03066661
- Sponsor
- Hoffmann-La Roche
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.